重复给予改良聚肌苷酸-聚胞苷酸复合物后食蟹猴和恒河猴体内的干扰素诱导情况。
Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex.
作者信息
Sammons M L, Stephen E L, Levy H B, Baron S, Hilmas D E
出版信息
Antimicrob Agents Chemother. 1977 Jan;11(1):80-3. doi: 10.1128/AAC.11.1.80.
Abstract
Serum interferon activity was determined in 12 cynomolgus and 12 rhesus monkeys injected intravenously once daily for 10 days with from 0.1 to 6.0 mg of a stabilized polyriboinosinic acid . polyribocytidylic acid complex per kg, composed of polyriboinosinic acid . polyribocytidylic acid, poly-1-lysine, and carboxymethylcellulose [poly(ICLC)]. Interferon activity was detected 2 h after the first injection, with maximum activity occurring 8 h after the second injection. A period of hyporesponsiveness occurred after the third injection of poly(ICLC) in all monkeys and lasted until the sixth injection in the rhesus monkeys, when interferon activity again became more elevated. The delayed rebound was not as apparent in cynomolgus monkeys. Rhesus monkeys injected with 6 mg/kg did not exhibit serious side effects.
摘要
给12只食蟹猴和12只恒河猴静脉注射由聚肌苷酸·聚胞苷酸、聚-L-赖氨酸和羧甲基纤维素组成的稳定化聚肌苷酸-聚胞苷酸复合物[聚（ICLC）]，剂量为每千克0.1至6.0毫克，每日一次，持续10天，然后测定血清干扰素活性。首次注射后2小时检测到干扰素活性，第二次注射后8小时出现最大活性。所有猴子在第三次注射聚（ICLC）后都出现了一段低反应期，恒河猴持续到第六次注射，此时干扰素活性再次升高。延迟反弹在食蟹猴中不那么明显。注射6毫克/千克的恒河猴未出现严重副作用。
相似文献
1
Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex.重复给予改良聚肌苷酸-聚胞苷酸复合物后食蟹猴和恒河猴体内的干扰素诱导情况。
Antimicrob Agents Chemother. 1977 Jan;11(1):80-3. doi: 10.1128/AAC.11.1.80.
2
Protective and toxic effects of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid on Venezuelan equine encephalomyelitis virus in rhesus monkeys.聚肌苷酸-聚胞苷酸的一种核酸酶抗性衍生物对恒河猴委内瑞拉马脑炎病毒的保护和毒性作用。
J Infect Dis. 1979 Mar;139(3):267-72. doi: 10.1093/infdis/139.3.267.
3
Interferon induction in primates by stabilized polyriboinosinic acid-polyribocytidylic acid: effect of component size.稳定化聚肌苷酸-聚胞苷酸在灵长类动物中诱导干扰素：组分大小的影响
Infect Immun. 1981 Nov;34(2):416-21. doi: 10.1128/iai.34.2.416-421.1981.
4
A comparison of interferon responses to poly ICLC in males and females.男性和女性对聚肌胞苷酸（poly ICLC）的干扰素反应比较。
J Interferon Res. 1992 May;Spec No:85-90. doi: 10.1089/jir.1992.1992.85.
5
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates.一种能在灵长类动物中诱导干扰素产生的改良聚肌苷酸-聚胞苷酸复合物。
J Infect Dis. 1975 Oct;132(4):434-9. doi: 10.1093/infdis/132.4.434.
6
Polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex [poly(ICL)] without carboxymethylcellulose (CMC): a new primate-effective interferon inducer.不含羧甲基纤维素（CMC）的聚肌苷酸-聚胞苷酸-聚-L-赖氨酸复合物[聚（ICL）]：一种新型的对灵长类有效的干扰素诱导剂。
Proc Soc Exp Biol Med. 1982 Feb;169(2):183-8. doi: 10.3181/00379727-169-41329.
7
A comparison of interferon responses to poly ICLC in males and females.男性和女性对聚肌胞苷酸（poly ICLC）的干扰素反应比较。
J Interferon Res. 1985 Summer;5(3):423-8. doi: 10.1089/jir.1985.5.423.
8
Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits.修饰的聚肌苷酸-聚胞苷酸复合物：对兔血清干扰素、发热及低血压的诱导作用
Antimicrob Agents Chemother. 1980 Jan;17(1):49-54. doi: 10.1128/AAC.17.1.49.
9
Tumor response to interferon inducer and radiation effect of serum interferon levels.肿瘤对干扰素诱导剂的反应及血清干扰素水平的辐射效应。
J Biol Regul Homeost Agents. 1988 Jan-Mar;2(1):1-6.
10
Pharmacokinetics of interferon in blood, cerebrospinal fluid, and brain after administration of modified polyriboinosinic-polyribocytidylic acid and amphotericin B.给予修饰的聚肌苷酸-聚胞苷酸和两性霉素B后干扰素在血液、脑脊液及脑内的药代动力学
J Infect Dis. 1982 Dec;146(6):819-25. doi: 10.1093/infdis/146.6.819.
引用本文的文献
1
Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events.肿瘤内注射聚肌胞苷酸（Poly-ICLC）治疗晚期癌症犬：临床疗效、生活质量及不良事件的首次报告
Cancers (Basel). 2021 May 7;13(9):2237. doi: 10.3390/cancers13092237.
2
Nucleic Acid Immunotherapeutics for Cancer.癌症的核酸免疫疗法
ACS Appl Bio Mater. 2020 May 18;3(5):2838-2849. doi: 10.1021/acsabm.0c00101. Epub 2020 Mar 16.
3
Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice.MDA5 和干扰素-I 在抗肿瘤肽疫苗诱导小鼠 T 细胞扩增中的树突状细胞作用。
Cancer Immunol Immunother. 2018 Jul;67(7):1091-1103. doi: 10.1007/s00262-018-2164-6. Epub 2018 Apr 25.
4
The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.1893年至2014年非人灵长类动物在季节性、大流行性和禽流感研究中的应用
Antiviral Res. 2015 May;117:75-98. doi: 10.1016/j.antiviral.2015.02.011. Epub 2015 Mar 5.
5
Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.Toll样受体激动剂通过短暂的免疫激活增强病毒样颗粒介导的对埃博拉病毒的保护作用。
PLoS One. 2014 Feb 24;9(2):e89735. doi: 10.1371/journal.pone.0089735. eCollection 2014.
6
Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques.合成双链RNA是诱导恒河猴对人乳头瘤病毒产生辅助性T细胞1型和体液免疫反应的佐剂。
PLoS Pathog. 2009 Apr;5(4):e1000373. doi: 10.1371/journal.ppat.1000373. Epub 2009 Apr 10.
7
Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology Group.低剂量干扰素诱导剂聚肌胞苷酸在晚期肾癌及复发或难治性淋巴瘤中的毒性及反应评估：东部肿瘤协作组两项临床试验报告
Invest New Drugs. 2001;19(1):89-92. doi: 10.1023/a:1006458232384.
8
Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits.修饰的聚肌苷酸-聚胞苷酸复合物：对兔血清干扰素、发热及低血压的诱导作用
Antimicrob Agents Chemother. 1980 Jan;17(1):49-54. doi: 10.1128/AAC.17.1.49.
9
Variations in the contribution of induced interferon and adjuvanticity to the antiviral effect of different polyinosinic acid . polycytidylic acid formulations in mice infected with encephalomyocarditis virus.诱导干扰素的贡献及佐剂活性对不同聚肌苷酸-聚胞苷酸制剂在感染脑心肌炎病毒小鼠中抗病毒作用的影响差异
Infect Immun. 1980 Sep;29(3):960-5. doi: 10.1128/iai.29.3.960-965.1980.
10
Modified polyriboinosinic-polyribocytidylic acid complex: modulation of toxicity for rabbits by alterations in components.修饰的聚肌苷酸-聚胞苷酸复合物：通过改变成分对家兔毒性的调节
Antimicrob Agents Chemother. 1980 Sep;18(3):409-15. doi: 10.1128/AAC.18.3.409.
本文引用的文献
1
Tolerance to the induction of interferons by endotoxin and virus: role of a humoral factor.
Proc Soc Exp Biol Med. 1965 Aug-Sep;119(4):1227-32. doi: 10.3181/00379727-119-30421.
2
Kinetics of serum interferon response in mice after single and multiple injections of polyI-poly C.
Proc Soc Exp Biol Med. 1971 Feb;136(2):394-8. doi: 10.3181/00379727-136-35272.
3
The interferon refractory state: in vivo and in vitro studies of its mechanism.干扰素难治性状态：其机制的体内和体外研究
J Immunol. 1971 Jan;106(1):134-42.
4
Polyriboinosinic-polyribocytidylic acid-induced interferons in calves.
Am J Vet Res. 1971 Jan;32(1):35-9.
5
Relationship between dose size and dose interval of polyinosinic polycytidylic acid and interferon hyporesponsiveness in mice.小鼠中聚肌苷酸-聚胞苷酸的剂量大小与剂量间隔和干扰素低反应性之间的关系
Proc Soc Exp Biol Med. 1970 Nov;135(2):340-4. doi: 10.3181/00379727-135-35047.
6
Inhibition of biologic activity of poly I: poly C by human plasma.
Proc Soc Exp Biol Med. 1970 Feb;133(2):439-44. doi: 10.3181/00379727-133-34492.
7
Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes.干扰素与宿主抗性的诱导剂。II. 多链合成多核苷酸复合物。
Proc Natl Acad Sci U S A. 1967 Sep;58(3):1004-10. doi: 10.1073/pnas.58.3.1004.
8
Studies on poly I:C toxicity in experimental animals.实验动物中聚肌胞苷酸毒性的研究。
Toxicol Appl Pharmacol. 1972 Dec;23(4):579-88. doi: 10.1016/0041-008x(72)90098-1.
9
Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents.感染反应低下：干扰素诱导剂治疗应用的潜在限制
Infect Immun. 1972 Nov;6(5):743-7. doi: 10.1128/iai.6.5.743-747.1972.
10
The effect of interferon, interferon inducers or interferon induced virus resistance on subsequent interferon production.干扰素、干扰素诱导剂或干扰素诱导的病毒抗性对后续干扰素产生的影响。
J Gen Virol. 1972 May;15(2):119-28. doi: 10.1099/0022-1317-15-2-119.
Zotero 插件